Search inside SEC filings
Every 10-K, 10-Q, 8-K, proxy and registration statement filed since 2001, searched by what the text actually says. Free, no account, straight through to the document.
6,476 filings contain "Quince"
showing the first 40- Quince Run Acquisition Corp10-12G · 2013-09-30Read the filing on SEC.gov →
- Quince Therapeutics, Inc. (QNCX)10-K · 2025-03-24Read the filing on SEC.gov →
- Quince Therapeutics, Inc. (QNCX)8-K · 2025-08-11Read the filing on SEC.gov →
- Quince Therapeutics, Inc. (QNCX)8-A12B · 2023-04-05Read the filing on SEC.gov →
- Quince Run Acquisition Corp10-12G/A · 2013-12-09Read the filing on SEC.gov →
- Quince Run Acquisition Corp10-K · 2014-03-26Read the filing on SEC.gov →
- Quince Therapeutics, Inc. (QNCX)8-K · 2023-04-05Read the filing on SEC.gov →
- Cartesian Therapeutics, Inc. (RNAC)D · 2024-07-17Read the filing on SEC.gov →
- OPGEN INC (OPGN)D · 2015-07-23Read the filing on SEC.gov →
- Quince Therapeutics, Inc. (QNCX)8-K · 2025-03-24Read the filing on SEC.gov →
- Quince Therapeutics, Inc. (QNCX)8-K/A · 2026-07-30Read the filing on SEC.gov →
- Quince Run Acquisition Corp10-12G/A · 2014-01-23Read the filing on SEC.gov →
- Quince Therapeutics, Inc. (QNCX)8-K · 2026-05-18Read the filing on SEC.gov →
- HEADWATERS INCSC 13G/A · 2001-06-20Read the filing on SEC.gov →
- Quince Therapeutics, Inc. (QNCX)8-K · 2025-07-16Read the filing on SEC.gov →
- OPGEN INC (OPGN)D · 2012-03-14Read the filing on SEC.gov →
- Adaptive Phage Therapeutics, Inc.D · 2023-06-09Read the filing on SEC.gov →
- CLS Holdings USA, Inc. (CLSH)8-K · 2015-04-30Read the filing on SEC.gov →
- OPGEN INC (OPGN)D · 2021-02-24Read the filing on SEC.gov →
- OPGEN INC (OPGN)D · 2014-07-17Read the filing on SEC.gov →
- Quince Run Acquisition Corp10-Q · 2014-05-15Read the filing on SEC.gov →
- OPGEN INC (OPGN)D · 2011-12-09Read the filing on SEC.gov →
- Quince Therapeutics, Inc. (QNCX)8-K · 2024-11-13Read the filing on SEC.gov →
- Cartesian Therapeutics, Inc. (RNAC)D/A · 2023-12-04Read the filing on SEC.gov →
- Quince Therapeutics, Inc. (QNCX)8-K · 2023-10-23Read the filing on SEC.gov →
- Quince Therapeutics, Inc. (QNCX)8-K · 2023-07-24Read the filing on SEC.gov →
- OPGEN INC (OPGN)D · 2013-12-30Read the filing on SEC.gov →
- Quince Therapeutics, Inc. (QNCX)8-K/A · 2024-01-05Read the filing on SEC.gov →
- Quince Therapeutics, Inc. (QNCX)8-K · 2026-01-29Read the filing on SEC.gov →
- Cartesian Therapeutics, Inc. (RNAC)D · 2023-12-01Read the filing on SEC.gov →
- OPGEN INC (OPGN)D/A · 2010-01-15Read the filing on SEC.gov →
- Quince Therapeutics, Inc. (QNCX)8-K · 2025-11-12Read the filing on SEC.gov →
- OPGEN INC (OPGN)D · 2017-09-21Read the filing on SEC.gov →
- Quince Therapeutics, Inc. (QNCX)8-K · 2025-05-13Read the filing on SEC.gov →
- Quince Therapeutics, Inc. (QNCX)8-K · 2026-03-30Read the filing on SEC.gov →
- Quince Therapeutics, Inc. (QNCX)8-K · 2025-10-17Read the filing on SEC.gov →
- OPGEN INC (OPGN)D/A · 2014-04-04Read the filing on SEC.gov →
- FRANKLIN CAPITAL CORP8-K · 2004-07-23Read the filing on SEC.gov →
- OPGEN INC (OPGN)D/A · 2010-05-10Read the filing on SEC.gov →
- Adaptive Phage Therapeutics, Inc.D · 2021-05-20Read the filing on SEC.gov →
Source: the SEC’s own EDGAR full-text index, which covers filings from 2001onward. Results are ordered by EDGAR’s relevance. A filing appearing here means the phrase is in the document, nothing more.